MONTEREY, CA, USA (UroToday.com) - In his State-of-the-Art talk, Colin Collins discussed biomarkers for prostate cancer (CaP) risk stratification.
Your session will expire in 8 hours requiring you to log in each day to view content.
MONTEREY, CA, USA (UroToday.com) - In his State-of-the-Art talk, Colin Collins discussed biomarkers for prostate cancer (CaP) risk stratification.